Your browser doesn't support javascript.
loading
The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries.
Halpin, D M G; Celli, B R; Criner, G J; Frith, P; López Varela, M V; Salvi, S; Vogelmeier, C F; Chen, R; Mortimer, K; Montes de Oca, M; Aisanov, Z; Obaseki, D; Decker, R; Agusti, A.
Afiliación
  • Halpin DMG; University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK.
  • Celli BR; Pulmonary Division, Brigham and Women's Hospital, Boston, MA.
  • Criner GJ; Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
  • Frith P; Flinders University College of Medicine and Public Health, Adelaide, SA, Australia.
  • López Varela MV; Cátedra de Neumología, Facultad de Medicina, Universidad de la República Hospital Maciel, Montevideo, Uruguay.
  • Salvi S; Chest Research Foundation, Pune, India.
  • Vogelmeier CF; Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Centre Giessen and Marburg (Member of the German Center for Lung Research, DZL), Philipps-Universität Marburg, Germany.
  • Chen R; Guangzhou Institute of Respiratory Disease, State Key Lab of Respiratory Disease & National Clinical Research Center for Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Mortimer K; Liverpool School of Tropical Medicine, Liverpool, UK.
  • Montes de Oca M; Hospital Universitario de Caracas, Universidad Central de Venezuela, Caracas, Venezuela.
  • Aisanov Z; Department of Pulmonology, N I Pirogov Russian State National Research Medical University, Healthcare Ministry of Russia, Moscow, Russia.
  • Obaseki D; Department of Medicine, Obafemi Awolowo University, Ile-Ife, Nigeria.
  • Decker R; Global Initiative for Chronic Obstructive Lung Disease, Fontana, WI, USA.
  • Agusti A; Institut Respiratori, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona, Centro de Investigación Biomédica en Red Enfermedades Respiratorias Spain, Barcelona, Spain.
Int J Tuberc Lung Dis ; 23(11): 1131-1141, 2019 11 01.
Article en En | MEDLINE | ID: mdl-31718748
ABSTRACT
Chronic obstructive pulmonary disease (COPD) is one of the top three causes of death worldwide, but governments and non-governmental organisations have not given its prevention and treatment the priority it requires. This is particularly true in low- and middle-income countries, where most of the people suffering from this disease live. The United Nations (UN) has targeted a reduction of premature deaths from non-communicable diseases (NCDs) by a third by 2030; however, a coordinated UN/World Health Organization (WHO) strategy to address the burden of COPD (one of the most important NCDs) is still lacking. To explore the extent of the problem and inform the development of policies to improve the situation, the Board of Directors of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) held a 1-day Summit. The key themes that emerged were the need to ensure accurate data on prevalence, raise awareness of the disease among the public, healthcare professionals and governments, including the fact that COPD aetiology goes beyond smoking (and other inhaled pollutants) and includes poor lung development in early life, and ensure that spirometry and both pharmacological and non-pharmacological therapies are available and affordable. Here, we present the actions that must be taken to address the impact of COPD. We believe that the WHO is particularly well-positioned to co-ordinate an attack on COPD, and GOLD will do all it can to help and rally support.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Asunto principal: Enfermedad Pulmonar Obstructiva Crónica / Países en Desarrollo Tipo de estudio: Etiology_studies / Guideline / Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Tuberc Lung Dis Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Asunto principal: Enfermedad Pulmonar Obstructiva Crónica / Países en Desarrollo Tipo de estudio: Etiology_studies / Guideline / Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Tuberc Lung Dis Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido